Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the amiodarone reduction in coronary heart (ARCH) trial
Thomas Guarnieri, MD, FACCa,
Shellee Nolan, MD, FACCa,
Sidney O. Gottlieb, MD, FACCa,
Audrey Dudek, RN, MSNa and
David R. Lowry, DrPHa
a St. Joseph Medical Center, Baltimore, Maryland, USA. Intravenous amiodarone was provided by Wyeth-Ayerst

View larger version (22K):
[in a new window]
|
Figure 1 Displayed is the freedom-from-atrial fibrillation in the days after open heart surgery. Both populations have complete follow-up to 30 days. (Solid diamond = placebo group; open square = amiodarone group.)
|
|
|